Why Is AT&T Stock Dropping?
The telecommunications giant AT&T Inc. (NYSE:T) has perhaps surprisingly eclipsed…
Sell
47
AFYA Quote, Financials, Valuation and Earnings
Last price:
$15.75
Seasonality move
:
-12.48%
Day range:
$15.66 - $15.95
52-week range:
$14.52 - $22.48
Dividend yield:
0%
P/E ratio:
12.71x
P/S ratio:
2.36x
P/B ratio:
1.88x
Volume:
68.7K
Avg. volume:
99.3K
1-year change:
-28.26%
Market cap:
$1.4B
Revenue:
$576.2M
EPS (TTM):
$1.24
Analysts' Opinion
-
Consensus RatingAfya has received a consensus rating of Hold. The company's average rating is a Hold based on 1 Buy rating, 5 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $19.72, Afya has an estimated upside of 25.3% from its current price of $15.74.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $16.14 representing -2.57% downside risk from its current price of $15.74.
Fair Value
-
According to the consensus of 6 analysts, Afya has 25.3% upside to fair value with a price target of $19.72 per share.
AFYA vs. S&P 500
-
Over the past 5 trading days, Afya has overperformed the S&P 500 by 2.31% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Afya does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Afya has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Afya reported revenues of $151.6M.
Earnings Growth
-
Afya has grown year-over-year earnings for 5 quarters straight. In the most recent quarter Afya reported earnings per share of $0.24.
Enterprise value:
1.7B
EV / Invested capital:
--
Price / LTM sales:
2.36x
EV / EBIT:
9.07x
EV / Revenue:
2.71x
PEG ratio (5yr expected):
0.21x
EV / Free cash flow:
10.58x
Price / Operating cash flow:
9.22x
Enterprise value / EBITDA:
6.75x
Gross Profit (TTM):
$385M
Return On Assets:
7.35%
Net Income Margin (TTM):
18.3%
Return On Equity:
15.17%
Return On Invested Capital:
10.16%
Operating Margin:
27.76%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | $430.1M | $539.5M | $616.8M | $148.1M | $151.6M | |
| Gross Profit | $272.3M | $330.5M | $385M | $89.1M | $93.2M | |
| Operating Income | $121.2M | $146.4M | $179.2M | $38.8M | $42.1M | |
| EBITDA | $168M | $209.6M | $247.6M | $57.7M | $56.9M | |
| Diluted EPS | $0.75 | $0.78 | $1.24 | $0.21 | $0.24 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $243.1M | $264.6M | $224.8M | $282.5M | $271.6M | |
| Total Assets | $718.5M | $1.2B | $1.3B | $1.6B | $1.6B | |
| Current Liabilities | $101.6M | $121.7M | $180.9M | $239.6M | $170.2M | |
| Total Liabilities | $227.9M | $633.7M | $664.4M | $850.3M | $839.2M | |
| Total Equity | $490.6M | $563.8M | $587.8M | $704.8M | $763.7M | |
| Total Debt | $42M | $267.9M | $271.4M | $389M | $394.6M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $152.6M | $210.5M | $232.5M | $74.9M | $78.9M | |
| Cash From Investing | -$116.8M | -$219.5M | -$213.1M | -$37.3M | -$108.9M | |
| Cash From Financing | -$96.1M | $26.8M | -$19.6M | -$22.1M | $50M | |
| Free Cash Flow | $92.4M | $156.9M | $158M | $63.8M | $48.1M | |
AFYA
Sector
Market Cap
$1.4B
$465.6M
Price % of 52-Week High
70.02%
72.07%
Dividend Yield
0%
0%
Shareholder Yield
--
3.59%
1-Year Price Total Return
-28.26%
-9.69%
Beta (5-Year)
0.894
0.958
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Buy
Level
$15.31
200-day SMA
Sell
Level
$16.97
Bollinger Bands (100)
Sell
Level
15.62 - 17.18
Chaikin Money Flow
Buy
Level
697.1K
20-day SMA
Buy
Level
$15.39
Relative Strength Index (RSI14)
Buy
Level
52.98
ADX Line
Buy
Level
28.94
Williams %R
Neutral
Level
-29.3233
50-day SMA
Sell
Level
$16.09
MACD (12, 26)
Sell
Level
-0.14
25-day Aroon Oscillator
Sell
Level
-20
On Balance Volume
Neutral
Level
9.9M
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (2.4489)
Buy
CA Score
(Annual)
Level (0.0124)
Buy
Beneish M-Score
(Annual)
Level (-2.5426)
Sell
Momentum Score
Level (3)
Buy
Ohlson Score
Level (0.1659)
Buy
Piotroski F Score
(Annual)
Level (6)
Sell
Quality Ratio Score
Level (4)
Buy
Fundamental Score
Level (9)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Afya Ltd is a medical education group based in Brazil. Its education portfolio has several courses in addition to Medicine, such as Management, Dentistry, Law, Engineering, Nursing, Psychology, and Accounting Sciences, among others. It has three segments; Undergrad provides educational services through undergraduate courses related to medicine, other health sciences, and other undergraduate programs, Continuing Education provides specialization programs and graduate courses in medicine; and Digital Services provides content and technology for medical education, clinical decisions software, practice management tools (that encompass electronic medical records, telemedicine, and digital prescription, and provides access, demand and efficiency for the healthcare players.
Stock Forecast FAQ
In the current month, AFYA has received 1 Buy ratings 5 Hold ratings, and 0 Sell ratings. The AFYA average analyst price target in the past 3 months is $19.72.
-
Where Will Afya Stock Be In 1 Year?
According to analysts, the consensus estimate is that Afya share price will rise to $19.72 per share over the next 12 months.
-
What Do Analysts Say About Afya?
Analysts are divided on their view about Afya share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Afya is a Sell and believe this share price will drop from its current level to $16.14.
-
What Is Afya's Price Target?
The price target for Afya over the next 1-year time period is forecast to be $19.72 according to 6 Wall Street analysts, 1 of them rates the stock a Buy, 0 rate the stock a Sell, and 5 analysts rate the stock a Hold.
-
Is AFYA A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Afya is a Hold. 5 of 6 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of AFYA?
You can purchase shares of Afya via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Afya shares.
-
What Is The Afya Share Price Today?
Afya was last trading at $15.75 per share. This represents the most recent stock quote for Afya. Yesterday, Afya closed at $15.74 per share.
-
How To Buy Afya Stock Online?
In order to purchase Afya stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is American Express Stock Going Lower?
American Express Company (NYSE:AXP) has long been a Buffett favorite…
Cigna vs Costco Stock: Which Is Best?
Cigna and Costco don’t usually go hand in hand but…
Stock Ideas
Sell
46
Is AAPL Stock a Buy?
Market Cap: $3.5T
P/E Ratio: 38x
Buy
51
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 115x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 36x
Alerts
Sell
45
QMCO alert for Jan 18
Quantum [QMCO] is down 15.61% over the past day.
Buy
51
QRVO alert for Jan 18
Qorvo [QRVO] is up 14.47% over the past day.
Sell
31
ATEX alert for Jan 18
Anterix [ATEX] is up 11.14% over the past day.
